NEXTURNBIOSCIENCE Co., Ltd. (KOSDAQ: 089140)

NEXTURNBIOSCIENCE Balance Sheet

Financials in millions KRW. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2010
Period Ending	Jun 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2010
Cash & Equivalents	14,829	13,737	10,644	20,632	52,700	-
Short-Term Investments	2,200	2,260	12,425	11,500	-	-
Trading Asset Securities	19,126	15,144	5,078	9,051	1,260	-
Cash & Short-Term Investments	36,155	31,141	28,147	41,184	53,960	5,935
Cash Growth	-32.63%	10.64%	-31.66%	-23.68%	809.25%	45.31%
Accounts Receivable	2,945	6,713	5,963	2,753	3,085	-
Other Receivables	586.23	958.61	2,081	1,229	-	-
Receivables	8,217	8,701	8,353	4,301	4,788	-
Inventory	9,303	6,247	7,023	5,352	6,982	-
Prepaid Expenses	109.24	75.47	121.12	51.8	19.25	-
Other Current Assets	70.4	612.59	322.12	57.62	1,037	-
Total Current Assets	53,855	46,777	43,966	50,946	66,786	-
Property, Plant & Equipment	27,677	27,955	28,628	12,662	16,043	-
Long-Term Investments	78,685	83,476	42,099	55,221	3,650	-
Goodwill	1,656	1,656	1,656	-	-	-
Other Intangible Assets	1,040	1,168	2,205	123.23	136.15	-
Long-Term Accounts Receivable	81,693	81,191	80,238	-	-	-
Long-Term Deferred Tax Assets	-	-	-	509.21	798.98	-
Long-Term Deferred Charges	0	0	0	0	0	-
Other Long-Term Assets	1,979	1,771	1,466	19,487	11,937	-
Total Assets	246,585	243,994	200,257	138,949	99,351	-
Accounts Payable	2,283	2,882	4,147	946.83	717.07	-
Accrued Expenses	459.88	555.68	593.37	236.14	118.81	-
Short-Term Debt	19,849	10,846	8,236	25,456	-	-
Current Portion of Long-Term Debt	-	64,375	625	-	-	-
Current Portion of Leases	703.75	798.78	803.49	732.96	22.52	-
Current Income Taxes Payable	502.61	3,274	8.2	127.62	-	-
Current Unearned Revenue	60.52	87.83	42.71	-	40.02	-
Other Current Liabilities	3,998	10,854	5,246	15,718	1,170	-
Total Current Liabilities	27,856	93,672	19,702	43,218	2,069	-
Long-Term Debt	64,000	-	64,375	-	-	-
Long-Term Leases	479.92	749.74	1,519	2,186	17.87	-
Long-Term Deferred Tax Liabilities	6,423	6,553	2,046	-	-	-
Other Long-Term Liabilities	5,083	5,006	3,922	578.85	304.8	-
Total Liabilities	103,841	105,981	91,983	46,214	2,583	-
Common Stock	28,207	23,509	19,427	16,610	5,923	-
Additional Paid-In Capital	64,062	61,033	45,093	35,733	46,494	-
Retained Earnings	50,112	53,083	43,821	46,734	51,341	-
Treasury Stock	-81.25	-81.25	-	-6,990	-6,990	-
Comprensive Income & Other	445.48	470	-66.18	646.76	-0	-
Shareholders' Equity	142,744	138,014	108,274	92,735	96,768	21,617
Total Liabilities & Equity	246,585	243,994	200,257	138,949	99,351	-
Total Debt	85,033	76,769	75,558	28,375	40.39	-
Net Cash (Debt)	-48,877	-45,628	-47,412	12,808	53,920	5,935
Net Cash Growth	-	-	-	-76.25%	808.57%	45.31%
Net Cash Per Share	-4982.44	-4523.61	-6984.29	1997.46	8408.77	-
Filing Date Shares Outstanding	11.28	9.4	7.77	6.41	6.41	-
Total Common Shares Outstanding	11.28	9.4	7.77	6.41	6.41	-
Working Capital	25,999	-46,895	24,264	7,728	64,717	-
Book Value Per Share	12658.93	14686.92	13933.75	14462.04	15090.95	4471.76
Tangible Book Value	140,049	135,190	104,414	92,612	96,632	21,428
Tangible Book Value Per Share	12419.91	14386.39	13436.98	14442.82	15069.72	4432.59
Land	19,143	19,143	19,143	5,013	9,767	-
Buildings	7,938	7,938	8,071	4,426	6,661	-
Machinery	9,987	9,625	11,114	5,451	5,497	-
Construction In Progress	65.5	82.5	-	-	-	-

Source: S&P Capital IQ. Standard template. Financial Sources.